Abiraterone acetate

CYP17 inhibitor, prostate cancer

Signals from filings dated January 2026 – January 2026 · Last checked 15 Nov 2026

Supply outlook

↑ GROWING

In the filings we track: 1 plant adding this molecule, 0 exit signals, 0 intermediate projects.

↑ Coming in1 plant+20 t/yr, where filed in tonnes
↓ Leaving0no drops or surrenders found
⇄ Own intermediates0no KSM projects found
Furthest stageEIA approvedapproval is not production

Signals

Why capacity is shown as filed →

Who makes Abiraterone acetate today: 17 listings

Current manufacturers with US DMF and CEP status, plant addresses and contacts.

See all manufacturers →
ManufacturerCountryUS DMFCEPContact
Chongqing Pharmaceutical Research Institute Co LtdChina✓—In database
Olon SpAItaly✓—In database
Raks PharmaIndia✓—In database
+ 14 more listings in api-fdf.com →

Three examples from the api-fdf.com database, refreshed weekly. Plant addresses and contacts are shown in the database.

Follow Abiraterone acetate

Get an email when a new filing adds, cuts or moves this molecule to the next stage.

Follow

Other molecules with signals